All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Merck refinances €2bn RCF with oversubscribed line

German pharmaceuticals firm Merck has refinanced a €2bn revolver maturing in 2014 with a new facility of the same size.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree